Opthea Limited (NASDAQ:OPT), a biopharmaceutical company with a market capitalization of $894.5 million specializing in the ...

Opthea (ASX/NASDAQ:OPT) is a biopharmaceutical company developing novel therapies to treat vision-threatening eye diseases, including wet age-related macular degeneration (wet AMD) and diabetic ...

Long-term stabilizing of retinal exudation and fluid accumulation contributes to brolucizumab’s efficacy in managing wet age-related macular degeneration (AMD). Visual prognosis could be improved when ...

But what’s the difference between dry dusting and wet dusting? And who wins the dry dusting vs wet dusting battle? I’ve ...

Lower rates of both progression of macular fibrosis and intravitreal aflibercept injections were found in those who used the ...

Age-related macular degeneration may cause a gradual reduction in your central vision over time, so you might not recognize ...

"Lorem ipsum dolor sit amet, consectetur adipiscing elit, sed do eiusmod tempor incididunt ut labore et dolore magna aliqua. Ut enim ad minim veniam, quis nostrud exercitation ullamco laboris nisi ut ...

Tonabersat is under clinical development by Inflammx Therapeutics and currently in Phase II for Dry (Atrophic) Macular Degeneration. According to GlobalData, Phase II drugs for Dry (Atrophic) Macular ...

Vorolanib is under clinical development by EyePoint Pharmaceuticals and currently in Phase III for Wet (Neovascular / Exudative ... It was also under development for the treatment of dry age-related ...

Do you really need to feed your cat wet food? It’s a question many pet owners ask themselves, especially since the cans and packets tend to be pricier than a bag of dry kibble. But all the vets ...